Packaging contractor Helvoet places stake in Asia; Merck, Emergent add staff;

> Belgium-based parenterals packager Helvoet Pharma is building a $26.5 million plant in India, expected to open in 2012, to establish an Asian presence. Story

> Merck has been adding staff to its vaccine manufacturing plant in Durham, NC, and expects to hire an additional 310 people over the next two years. Article

> Maryland-based Emergent Biosolutions continues to grow in Lansing, MI, as it ramps up production for its anthrax vaccine. News

> European CMO NextPharma says it has passed an inspection by Japanese regulator PMDA resulting in continued accreditation of its Brussels-area Braine-l'Alleud facility, used in aseptic production and the manufacture of cytotoxic products. Article

> Meridian Life Science of Memphis has completed a second clinical cGMP production lot of the live oral RV3 rotavirus vaccine candidate. Report

> Reliable Biopharmaceutical in St. Louis has named David Feldker its CEO and president, effective next month. Reliable release

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.